Key statistics
On Tuesday, Evotec SE (EVO:NSQ) closed at 3.26, 14.39% above the 52 week low of 2.85 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.28 |
---|---|
High | 3.28 |
Low | 3.21 |
Bid | 3.06 |
Offer | 3.63 |
Previous close | 3.34 |
Average volume | 118.24k |
---|---|
Shares outstanding | 355.11m |
Free float | 319.70m |
P/E (TTM) | -- |
Market cap | 1.18bn USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-DD: Evotec SE: Laetitia Rouxel, Restricted shares granted as Short-Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system
- EQS-News: Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
- EQS-News: Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU)
- EQS-DD: Evotec SE: Dr. Christian Wojczewski, buy
- EQS-DD: Evotec SE: Aurélie Dalbiez, buy
- EQS-News: Evotec announces change in Management Board
- EQS-DD: Evotec SE: Prof. Dr. Iris Löw-Friedrich, buy
- EQS-DD: Evotec SE: Dr. Craig Johnstone, buy
- EQS-News: Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
More ▼